,,ii #aad? ,,congress #a/ ,session ,s4 #aacd ,,9 ,,! ,,s5ate ,,( ,,! ,,unit$ ,,/ates ,april #bi1 #bjae ,ms4 ,ayotte 7= h]self & ,mr4 ,donnelly7 introduc$ ! foll[+ bill2 :i* 0 read twice & ref]r$ to ! ,committee on ! ,judici>y ,a ,,bill ,to address prescription opioid abuse & h]o9 use4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,h]o9 & ,prescription ,opioid ,abuse ,prev5tion1 ,education1 & ,en=cem5t ,act ( #bjae44 #b4 ,f9d+s ,congress makes ! foll[+ f9d+s3 7#a7 ,! ,controll$ ,sub/ances ,act 7#ba ,u4,s4,c4 #hja et seq47 decl>es t _m controll$ sub/ances h a useful & legitimate m$ical purpose & are necess>y to ma9ta9 ! heal? & g5]al welf>e ( ! p ( ! ,unit$ ,/ates4 7#b7 ,heal? c>e pr(essionals1 m$ical exp]ts1 rese>*]s1 & sci5ti/s h f\nd pa9 to be a major national heal? problem4 7#c7 ,! responsible treatm5t ( pa9 is a high priority = our ,nation & ! ne$s ( individuals ) pa9 mu/ be tak5 into c>eful consid]ation :5 tak+ /eps to prev5t prescription drug misuse & abuse4 7#d7 ,:5 no long] ne$$ or want$ = legitimate pa9 managem5t or heal? treatm5t1 prescription opioids are susceptible to div]sion4 ,prescription opioids also may be abus$ by individuals :o 7 n prescrib$ su* drugs1 or misus$ by individuals n tak+ su* drugs z direct$4 7#e7 ,approximately #d out ( #e new h]o9 us]s report t !y became addict$ to prescription opioids be=e !y us$ h]o9 = ! fir/ "t4 7#f7 ,accord+ to ! ,national ,in/itute on ,drug ,abuse1 h]o9 atta*es to ! same bra9 cell receptors z prescription opioids4 7#g7 ,! l[ co/ & high purity ( curr5tly available h]o9 has contribut$ to an increase 9 h]o9 use across ! ,unit$ ,/ates4 7#h7 ,m p are us+ h]o91 & are us+ h]o9 at a y\ng] age4 ,! ,national ,survey on ,drug ,use & ,heal? reports t new h]o9 us]s numb]$ #adb1jjj 9 #bjaj1 & increas$ to #agh1jjj 9 #bjaa4 ,9 #bjaa1 ! av]age age at fir/ use among h]o9 abus]s betwe5 #ab & #di ye>s 0 #bb4a ye>s4 ,9 #bjji1 ! av]age age at fir/ use among h]o9 abus]s betwe5 #ab & #di ye>s 0 #be4e ye>s4 7#i7 ,accord+ to ! ,dep>tm5t ( ,heal? & ,human ,s]vices1 h]o9 use nationwide rose #gi p]c5t betwe5 #bjjg & #bjab4 7#aj7 ,dea?s f h]o9 ov]dose h significantly increas$ 9 communities across ! ,unit$ ,/ates4 ,accord+ to ! ,c5t]s = ,disease ,control & ,prev5tion1 ! numb] ( dea?s involv+ h]o9 almo/ tripl$ betwe5 #bjaj & #bjac4 ,f #bjaj to #bjac1 ! numb] ( h]o9 dea?s rose f #c1jcf to #h1beg4 7#aa7 ,! ,edw>d ,byrne ,memorial ,ju/ice ,assi/ance ,grant ,program "u "p ,e ( title ,i ( ! ,omnibus ,crime ,control & ,safe ,/reets ,act ( #aifh 7#db ,u4,s4,c4 #cgej et seq47 is critical to fight+ ! prescription opioid abuse & h]o9 use epidemics1 & %\ld be reau?oriz$ & fully fund$4 #c4 ,developm5t ( be/ prescrib+ practices 7a7 ,int]-,ag5cy task =ce ,n lat] ?an #abj days aft] ! date ( enactm5t ( ?is ,act1 ! ,secret>y ( ,heal? & ,human ,s]vices 7ref]r$ to 9 ?is section z ! ,secret>y71 9 coop]ation ) ! ,secret>y ( ,vet]ans ,affairs1 ! ,secret>y ( ,def5se1 & ! ,adm9i/rator ( ! ,drug ,en=cem5t ,adm9i/ration1 %all conv5e a ,pa9 ,managem5t ,be/ ,practices ,int]-,ag5cy ,task ,=ce 7ref]r$ to 9 ?is section z ! task =ce74 7b7 ,memb]%ip ,! task =ce %all be compris$ (-- 7#a7 repres5tatives (-- 7,a7 ! ,dep>tm5t ( ,heal? & ,human ,s]vices1 includ+ ! ,c5t]s = ,disease ,control & ,prev5tion2 7,b7 ! ,dep>tm5t ( ,vet]ans ,affairs2 7,c7 ! ,dep>tm5t ( ,def5se2 7,d7 ! ,drug ,en=cem5t ,adm9i/ration2 7,e7 ! ,(fice ( ,national ,drug ,control ,policy2 & 7,f7 ! ,in/itute ( ,m$ic9e2 7#b7 ! ,director ( ! ,national ,in/itutes ( ,heal?2 7#c7 physicians1 d5ti/s1 & non-physician prescrib]s2 7#d7 ph>maci/s2 7#e7 exp]ts 9 ! fields ( pa9 rese>* & addiction rese>*2 7#f7 repres5tatives (-- 7,a7 pa9 managem5t pr(essional organizations2 7,b7 ! m5tal heal? treatm5t community2 7,c7 ! addiction treatm5t community2 & 7,d7 pa9 advocacy gr\ps2 & 7#g7 o!r /akehold]s1 z ! ,secret>y det]m9es appropriate4 7c7 ,duties ,! task =ce %all-- 7#a7 n lat] ?an #ahj days aft] ! date on :i* ! task =ce is conv5$1 develop be/ practices = pa9 managem5t & prescription pa9 m$ication prescrib+ practices1 tak+ into consid]ation-- 7,a7 exi/+ pa9 managem5t rese>*2 7,b7 recomm5dations f relevant conf]5ces2 & 7,c7 ongo+ ef=ts at ! ,/ate & local levels & by m$ical pr(essional organizations to develop improv$ pa9 managem5t /rategies2 7#b7 solicit & take into consid]ation public comm5t on ! be/ practices develop$ "u p>agraph 7#a71 am5d+ su* be/ practices if appropriate2 & 7#c7 develop a /rategy = dissem9at+ in=mation ab\t ! be/ practices develop$ "u p>agraphs 7#a7 & 7#b7 to prescrib]s1 ph>maci/s1 ,/ate m$ical bo>ds1 & o!r p>ties1 z ! ,secret>y det]m9es appropriate4 7d7 ,limitation ,! task =ce %all n h rulemak+ au?ority4 7e7 ,report ,n lat] ?an #bgj days aft] ! date on :i* ! task =ce is conv5$ "u subsection 7a71 ! task =ce %all submit to ,congress a report t includes-- 7#a7 ! /rategy = dissem9at+ be/ practices develop$ "u subsection 7c72 7#b7 ! results ( a feasibility /udy on l9k+ be/ practices develop$ "u p>agraphs 7#a7 & 7#b7 ( subsection 7c7 to receiv+ & r5ew+ regi/rations "u section #cjc7;f7 ( ! ,controll$ ,sub/ances ,act 7#ba ,u4,s4,c4 #hbc7;f772 & 7#c7 recomm5dations on h[ to apply su* be/ practices to improve prescrib+ practices at m$ical facilities1 includ+ m$ical facilities ( ! ,vet]ans ,heal? ,adm9i/ration4 #d4 ,h>old rog]s prescription drug monitor+ program 7a7 ,au?orization ( appropriations ,to c>ry out ! ,h>old ,rog]s ,prescription ,drug ,monitor+ ,program e/abli%$ "u ! ,dep>tm5ts ( ,comm]ce1 ,ju/ice1 & ,/ate1 ! ,judici>y1 & ,relat$ ,ag5cies ,appropriations ,act1 #bjjb 7,public ,law #ajg-gg2 #aae ,/at4 #gdh71 !re is au?oriz$ to be appropriat$ #i1jjj1jjj = ea* ( fiscal ye>s #bjaf ?r\gh #bjbj4 7b7 ,,gao ,report ,n lat] ?an #a ye> aft] ! date ( enactm5t ( ?is ,act1 ! ,comptroll] ,g5]al ( ! ,unit$ ,/ates %all submit to ,congress a report evaluat+ ! effectiv5ess ( ! ,h>old ,rog]s ,prescription ,drug ,monitor+ ,program 9 r$uc+ prescription drug abuse1 &1 to ! ext5t practicable1 any correspond+ increase or decrease 9 ! use ( h]o94 #e4 ,reau?orization ( byrne ju/ice assi/ance grant program ,section #ejh ( title ,i ( ! ,omnibus ,crime ,control & ,safe ,/reets ,act ( #aifh 7#db ,u4,s4,c4 #cgeh7 is am5d$ by /rik+ #bjjf ?r\gh #bjab & ins]t+ #bjaf ?r\gh #bjbj4 #f4 ,aw>5ess campaigns 7a7 ,9 g5]al ,! ,secret>y ( ,heal? & ,human ,s]vices %all advance ! education & aw>5ess ( ! public1 provid]s1 pati5ts1 & o!r appropriate /akehold]s reg>d+ ! risk ( abuse ( prescription opioid drugs if su* products are n tak5 z prescrib$4 7b7 ,drug-,free m$ia campaign 7#a7 ,9 g5]al ,! ,(fice ( ,national ,drug ,control ,policy1 9 coord9ation ) ! ,secret>y ( ,heal? & ,human ,s]vices & ! ,attorney ,g5]al1 %all e/abli% a national drug aw>5ess campaign4 7#b7 ,requirem5ts ,! national drug aw>5ess campaign "u p>agraph 7#a7 %all-- 7,a7 take into acc\nt ! association betwe5 prescription opioid abuse & h]o9 use2 7,b7 emphasize ! simil>ities betwe5 h]o9 & prescription opioids & ! effects ( h]o9 & prescription opioids on ! human body2 & 7,c7 br+ great] public aw>5ess to ! dang]\s effects ( f5tanyl :5 mix$ ) h]o9 or abus$ 9 a simil> mann]4 7#c7 ,available funds ,funds = ! national drug aw>5ess campaign may be d]iv$ f am\nts appropriat$ to ! ,(fice ( ,national ,drug ,control ,policy & o!rwise available = obligation & exp5diture4 #g4 ,naloxone demon/ration grants 7a7 ,def9itions ,9 ?is section-- 7#a7 ! t]m eligible entity means a ,/ate1 a unit ( local gov]nm5t1 or a tribal gov]nm5t2 7#b7 ! t]m fir/ respond] includes firefight]s1 law en=cem5t (fic]s1 p>am$ics1 em]g5cy m$ical te*nicians1 & o!r individuals 7includ+ employees ( legally organiz$ & recogniz$ volunte] organizations1 :e!r comp5sat$ or n71 :o1 9 ! c\rse ( pr(essional duties1 respond to fire1 m$ical1 haz>d\s mat]ial1 or o!r simil> em]g5cies2 & 7#c7 ! t]m opioid ov]dose rev]sal drug means a drug t1 :5 adm9i/]$1 rev]ses 9 :ole or "p ! ph>macological effects ( an opioid ov]dose 9 ! human body4 7b7 ,program au?oriz$ ,! ,attorney ,g5]al1 9 coord9ation ) ! ,secret>y ( ,heal? & ,human ,s]vices & ! ,director ( ! ,(fice ( ,national ,drug ,control ,policy1 may make grants to eligible entities to create n m ?an #h demon/ration programs to all[ prop]ly tra9$ fir/ respond]s to prev5t prescription opioid & h]o9 ov]dose dea? by adm9i/]+ an opioid ov]dose rev]sal drug to an individual :o has exp]i5c$ ov]dose or :o has be5 det]m9$ to h likely exp]i5c$ ov]dose4 7c7 ,application 7#a7 ,9 g5]al ,to be eligible to receive a grant "u ?is section1 an entity %all submit an application to ! ,attorney ,g5]al1 at su* "t1 9 su* mann]1 & accompani$ by su* in=mation z ! ,attorney ,g5]al %all require1 &-- 7,a7 t meets ! crit]ia = selection "u p>agraph 7#b72 & 7,b7 t describes-- 7i7 ! evid5ce-bas$ me?odology & outcome measures t w be us$ to evaluate ! program fund$ ) a grant "u ?is section1 & specifically expla9 h[ su* measurem5ts w provide valid measures ( ! impact ( ! program2 7ii7 h[ ! program c\ld be broadly replicat$ if demon/rat$ to be effective2 7iii7 h[ ! eligible entity w coord9ate ) _! correspond+ ,/ate sub/ance abuse ag5cy to id5tify protocols & res\rces t are available to victims & families1 includ+ in=mation on treatm5t & recov]y res\rces2 & 7iv7 h[ ! demon/ration program w cont9ue ) ,/ate1 local1 or private fund+ aft] ! expiration ( ! grant4 7#b7 ,crit]ia = selection ,! ,attorney ,g5]al may aw>d grants to eligible entities t demon/rate an in/itutional ne$ = te*nical support & lack exi/+ infra/ructure 9 ord] to implem5t & tra9 fir/ respond]s to c>ry out a demon/ration program "u p>agraph 7b74 7#c7 ,priority consid]ation ,9 aw>d+ grants "u ?is section1 ! ,attorney ,g5]al %all give priority to an eligible entity locat$ 9 a ,/ate t provides civil liability protection = fir/ respond]s adm9i/]+ an opioid ov]dose rev]sal drug to c\nt]act opioid ov]doses by-- 7,a7 enact+ legislation t provides su* civil liability protection2 & 7,b7 provid+ a c]tification by ! attorney g5]al ( ! ,/ate t ! attorney g5]al has-- 7i7 review$ any applicable civil liability protection law to det]m9e ! applicability ( ! law ) respect to fir/ respond]s :o may adm9i/] an opioid ov]dose rev]sal drug to individuals reasonably believ$ to be suff]+ f opioid ov]dose2 & 7ii7 conclud$ t ! law describ$ 9 subp>agraph 7,a7 provides adequate civil liability protection applicable to su* p]sons4 7d7 ,use ( funds ,an eligible entity %all use a grant receiv$ "u ?is section to-- 7#a7 make an opioid ov]dose rev]sal drug1 :i* may include naloxone1 available to be c>ri$ & adm9i/]$ by fir/ respond]s2 7#b7 tra9 & provide res\rces = fir/ respond]s1 on c>ry+ & adm9i/rat+ su* opioid ov]dose rev]sal drug = ! prev5tion ( prescription opioid & h]o9 ov]dose dea?s2 & 7#c7 e/abli% processes1 protocols1 & me*anisms = ref]ral to treatm5t4 7e7 ,te*nical support ,! ,attorney ,g5]al %all provide individualiz$ te*nical support1 z reque/$1 to grant recipi5ts "u ?is section to assi/ ) implem5tation ( ! demon/ration program4 7f7 ,grant duration ,a demon/ration project grant %all be = a p]iod ( #c ye>s4 7g7 ,evaluation ,foll[+ ! fir/ grant ye>1 a recipi5t ( a grant aw>d$ "u ?is section %all report to ! ,attorney ,g5]al on an annual basis -- 7#a7 ! numb] ( fir/ respond]s equipp$ ) an opioid ov]dose rev]sal drug = ! prev5tion ( fatal prescription opioid & h]o9 ov]dose2 7#b7 ! numb] ( prescription opioid & h]o9 ov]doses rev]s$ by fir/ respond]s2 7#c7 ! numb] ( calls = s]vice relat$ to prescription opioid & h]o9 ov]dose2 & 7#d7 ! ext5t to :i* ov]dose victims & families receive in=mation ab\t treatm5t s]vices & available data describ+ treatm5t admissions4 7h7 ,report to congress ,! ,attorney ,g5]al %all submit an annual report to ! appropriate committees ( ,congress aggregat+ ! data receiv$ f ! grant recipi5ts & evaluat+ ! outcomes a*iev$ by ! demon/ration projects fund$ "u ?is section4 #h4 ,(fset ,x is ! s5se ( ,congress t ! am\nts exp5d$ to c>ry out ?is ,act & ! am5dm5ts made by ?is ,act %\ld be (fset by a correspond+ r$uction 9 ,f$]al non-def5se discretion>y sp5d+4